INTRON BIOTECHNOLOGY, INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 048530 for the last quarter is 1.78 B KRW, and it's 6.92% lower compared to the previous quarter. The net income of Q2 24 is 579.25 M KRW.